Clinical trial
Vestipitant Or Vestipitant/Paroxetine Combination In Subjects With Tinnitus And…
NCT00394056 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00394056 |
|---|---|
| Title | Vestipitant Or Vestipitant/Paroxetine Combination In Subjects With Tinnitus And Hearing Loss. |
| Official title | Randomised, Double-blind, Placebo Controlled, Cross-over Study Comparing the Effects of Both Single Dose and Repeated Dosing Treatment for 14 Days of Vestipitant or Vestipitant / Paroxetine Combination in an Enriched Population of Subjects With Tinnitus & Hearing Loss |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Tinnitus |
| Intervention type | Drug, Other |
| Interventions | Vestipitant, Vestipitant + Paroxetine, Placebo |
| Enrollment | 26 |
| Start date | Dec 1, 2006 |
| Primary completion | Aug 1, 2009 |
| Completion | Aug 1, 2009 |
| First posted | Oct 31, 2006 |
| Last update posted | Oct 28, 2016 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: